An Integrated Preclinical Evaluation Of Dna-Repair Mechanisms In Determining Response To Peptide Receptor Radionuclide Therapy (Prrt) As A Guide To Patient Selection And For Development Of Novel Combination Therapies

Grant number: 810097 | Funding period: 2018 - 2022

Active